Quality in Upper Endoscopy

  • Imran Sheikh
  • Jeffrey TokarEmail author


Upper endoscopy is frequently performed in the evaluation of esophageal, gastric, and small bowel conditions. Quality in health care continues to receive increasing attention by healthcare institutions, payors, and regulatory agencies. This chapter discusses quality indicators that have been identified by the various GI societies in the USA (the ASGE, ACG, and AGA) and presents them in the time frames that have been suggested by the ASGE/ACG Task force: pre-procedural quality indicators, intra-procedural quality indicators, and post-procedural quality indicators.


Upper endoscopy Esophagogastroduodenoscopy Quality in endoscopy Quality indicators Priority quality indicators Performance metrics Barrett’s esophagus 

Supplementary material

Quality in upper endosopy (MP4 404861 kb)


  1. 1.
    Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(1179–87):e1–3.Google Scholar
  2. 2.
    Lohr KN, editor. Medicare: a strategy for quality assurance. Washington, DC: National Academy Press; 1990.Google Scholar
  3. 3.
    Park WG, Shaheen NJ, Cohen J, et al. Quality indicators for EGD. Gastrointest Endosc. 2015;81:17–30.CrossRefPubMedGoogle Scholar
  4. 4.
    Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA. 1998;280:1000–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Petersen BT. Quality assurance for endoscopists. Best Pract Res Clin Gastroenterol. 2011;25:349–60.CrossRefPubMedGoogle Scholar
  6. 6.
    Rizk MK, Sawhney MS, Cohen J, et al. Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc. 2015;81:3–16.CrossRefPubMedGoogle Scholar
  7. 7.
    Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81:31–53.CrossRefPubMedGoogle Scholar
  8. 8.
    Adler DG, Lieb II JG, Cohen J, et al. Quality indicators for ERCP. Gastrointest Endosc. 2015; 81:54–66.Google Scholar
  9. 9.
    Wani S, Wallace MB, Cohen J, et al. Quality indicators for EUS. Gastrointest Endosc. 2015;81:67–80.CrossRefPubMedGoogle Scholar
  10. 10.
    ASGE Standards of Practice Committee. Appropriate use of gastrointestinal endoscopy. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc. 2000;52:831–7.CrossRefGoogle Scholar
  11. 11.
    ASGE Standards of Practice Committee; Early DS, Ben-Menachem T, Decker GA, et al. Appropriate use of GI endoscopy. Gastrointest Endosc. 2012;75:1127–31.Google Scholar
  12. 12.
    Early DS, Ben-Menachem T, Decker GA, Evans JA, Fanelli RD, Fisher DA, et al. ASGE. Standards of practice committee. Appropriate use of GI endoscopy. Gastrointest Endosc. 2012;75:1127–31.CrossRefPubMedGoogle Scholar
  13. 13.
    Morini S, Hassan C, Meucci G, et al. Diagnostic yield of open access colonoscopy according to appropriateness. Gastrointest Endosc. 2001;54:175–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Froehlich F, Repond C, Mullhaupt B, et al. Is the diagnostic yield of upper GI endoscopy improved by the use of explicit panel-based appropriateness criteria? Gastrointest Endosc. 2000;52:333–41.CrossRefPubMedGoogle Scholar
  15. 15.
    Eisen GM, Baron TH, Dominitz JA, et al. Methods of granting hospital privileges to perform gastrointestinal endoscopy. Gastrointest Endosc. 2002;55:780–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Wexner SD, Litwin D, Cohen J, et al. Principles of privileging and credentialing for endoscopy and colonoscopy. Gastrointest Endosc. 2002;55:145–8.CrossRefPubMedGoogle Scholar
  17. 17.
    ASGE Standards of Practice Committee. ASGE quality indicators for clinical application. Methods of privileging for new technology in gastrointestinal endoscopy. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc. 1999;50:899–900.CrossRefGoogle Scholar
  18. 18.
    American Society for Gastrointestinal Endoscopy. Guideline: informed consent for gastrointestinal endoscopy. Gastrointest Endosc. 1988;34(Suppl):26S–7S.Google Scholar
  19. 19.
    Standards of Practice Committee; Zuckerman MJ, Shen B, Harrison ME III, et al. Informed consent for GI endoscopy. Gastrointest Endosc. 2007;66:213–8.Google Scholar
  20. 20.
    Pape T. Legal and ethical considerations of informed consent. AORN J. 1997;65:1122–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96:1004–17.Google Scholar
  22. 22.
    Enestvedt BK, Eisen GM, Holub J, et al. Is the American Society of Anesthesiologists classification useful in risk stratification for endoscopic procedures? Gastrointest Endosc. 2013;77:464–71.CrossRefPubMedGoogle Scholar
  23. 23.
    Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc;83:3–16.Google Scholar
  24. 24.
    Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev. 2006:CD005571.Google Scholar
  25. 25.
    Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy: a prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987;107:824–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Thomas S, Cantrill S, Waghorn DJ, et al. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther. 2007;25:593–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, et al. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010:CD002907.Google Scholar
  28. 28.
    Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–38.CrossRefPubMedGoogle Scholar
  29. 29.
    Fernandez J, Ruiz del Arbol L, Gomez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131:1049–56; quiz 1285.Google Scholar
  30. 30.
    Sreedharan A, Martin J, Leontiadis GI, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010:CD005415.Google Scholar
  31. 31.
    American Society of Anesthesiologists Task Force on Sedation, Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96:1004–17.CrossRefGoogle Scholar
  32. 32.
    Standards of Practice Committee; Lichtenstein DR, Jagannath S, Baron TH, et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2008;68:205–16.Google Scholar
  33. 33.
    ASGE Ensuring Safety in the Gastrointestinal Endoscopy Unit Task Force; Calderwood AH, Chapman FJ, Cohen J, et al. Quality indicators for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc. 2014;79:363–72.Google Scholar
  34. 34.
    Jeon J, Luebeck EG, Moolgavkar SH. Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). Cancer Causes Control. 2006;17:971–81.CrossRefPubMedGoogle Scholar
  35. 35.
    Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: The Prague C & M criteria. Gastroenterology. 2006;131:1392–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Wang KK, Sampliner RE. Practice parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–97.Google Scholar
  38. 38.
    Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG clinical guideline: diagnosis and management of Barrett’s Esophagus. Am J Gastroenterol. 2015 Nov 3. doi: 10.1038/ajg.2015.322. (Epub ahead of print).
  39. 39.
    Gupta N, Gaddam S, Wani SB, et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76:531–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Graham DY, Schwartz JT, Cain GD, et al. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology. 1982;82:228–31.PubMedGoogle Scholar
  41. 41.
    Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol. 2007;102:279–89; quiz 469.Google Scholar
  42. 42.
    Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107:345–60; quiz 361.Google Scholar
  43. 43.
    Villanueva C, Piqueras M, Aracil C, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006;45:560–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656–77.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152:101–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of GastroenterologyFox Chase Cancer CenterPhiladelphiaUSA

Personalised recommendations